Fifteen key stocks command investor attention Friday as major corporate developments unfold across sectors. Balaji Amines grapples with severe production disruptions stemming from West Asia conflict impacts on global shipping and LNG shortages, forcing ammonia supplier force majeure declarations. Multiple plants remain non-operational with financial effects still unquantifiable. Pharma major Zydus Lifesciences launches Diasens and GlucoLive, next-generation Continuous Glucose Monitoring devices featuring artificial intelligence and integrated remote care capabilities. Natural Biogenex executes framework agreements with Fermbox Bio for fermentation-based Contract Development Manufacturing services, positioning capacity for global biotechnology clients. Kalpataru Ltd announces redevelopment project wins in Mumbai Metropolitan Region.
